We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App





Vivalytic’s Rapid Coronavirus Test Delivers Results for Positive Samples in Less Than 30 Minutes

By LabMedica International staff writers
Posted on 21 Dec 2020
The Vivalytic SARS-CoV-2 rapid coronavirus test from Bosch Healthcare Solutions (Waiblingen, Germany) now delivers its results even faster due to improved software for the Vivalytic analysis device.

By applying optimized evaluation strategies, the Vivalytic analysis device can detect a positive SARS-CoV-2 sample through its high viral load in less than 30 minutes, right where the sample is collected. More...
The turnaround time for samples negative for SARS-CoV-2 is still 39 minutes. PCR tests are considered the gold standard, and Bosch’s rapid coronavirus tests have a sensitivity of 98% and a specificity of 100%. They are already available in 26 countries, mostly in Europe.

The CE marked Vivalytic SARS-CoV-2 rapid coronavirus test uses polymerase chain reaction (PCR) for detection. The new update is available for the SARS-CoV-2 singleplex test and the SARS-CoV-2 pooled test. Updating the Vivalytic testing devices is simple and straightforward - all that is required is an internet connection to access the Bosch cloud platform Vivasuite. Developed in-house at Bosch, the Vivasuite cloud platform allows users to digitally manage and update all their Bosch Healthcare Solutions devices. This is also an advantage when Vivalytic devices are in use in the field. The platform meets the strictest security standards and data privacy is guaranteed at all times: for example, there is no remote access to Vivalytic devices, and no possibility of accessing patient data.

“In the fight to contain the coronavirus pandemic, speed is of the essence,” said Dr. Volkmar Denner, chairman of the board of management of Robert Bosch GmbH. “With Vivalytic, we are delivering cutting-edge medical technology. Our IT and software expertise have helped to make the Bosch Corona test for positive samples even faster - all within a short period of time.”

Related Links:
Bosch Healthcare Solutions


Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
Online QC Software
Acusera 24•7
Manual Pipetting Aid
Pipette Controllers macro
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Prosigna test provides clinicians and patients with genomic insights to help make more informed breast cancer treatment decisions (Photo courtesy of Veracyte)

Genomic Test Guides Chemotherapy Decisions in Early-Stage Breast Cancer

Selecting adjuvant therapy for early-stage hormone receptor-positive breast cancer depends on accurately assessing long-term risk of distant recurrence. Clinical features alone can leave uncertainty about... Read more

Immunology

view channel
Image: New research shows that autoimmunity drives debilitating long COVID symptoms in a subset of patients (Image credit: Shutterstock)

Study Points to Autoimmune Pathway Behind Long COVID Symptoms

Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.